Serum AFP, PIVKA-II, GP3 and SCCA-1 levels were determined in 50 patients with HCC arising in a background of ALD or NAFLD cirrhosis. The gene discussed is AFP; the disease is metabolic dysfunction-associated steatotic liver disease.